Barclays
AXNX

Barclays’s Axonics, Inc. Common Stock AXNX Stock Holding History

Barclays’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-96,378
Closed -$6.71M – 5554
2024
Q3 		$6.71M Buy
96,378
+32,267
+50% +$2.21M ﹤0.01% 1800
2024
Q2 		$4.31M Sell
64,111
-2,024
-3% -$136K ﹤0.01% 1634
2024
Q1 		$4.56M Sell
66,135
-51,630
-44% -$3.48M ﹤0.01% 1927
2023
Q4 		$7.33M Buy
117,765
+51,381
+77% +$2.87M ﹤0.01% 1769
2023
Q3 		$3.73M Buy
66,384
+47,585
+253% +$2.68M ﹤0.01% 1510
2023
Q2 		$949K Sell
18,799
-6,091
-24% -$324K ﹤0.01% 2343
2023
Q1 		$1.36M Buy
24,890
+3,767
+18% +$220K ﹤0.01% 2507
2022
Q4 		$1.32M Sell
21,123
-4,556
-18% -$302K ﹤0.01% 2576
2022
Q3 		$1.81M Buy
25,679
+23,216
+943% +$1.6M ﹤0.01% 1822
2022
Q2 		$139K Sell
2,463
-5,403
-69% -$296K ﹤0.01% 3623
2022
Q1 		$493K Sell
7,866
-54,874
-87% -$2.96M ﹤0.01% 2919
2021
Q4 		$3.51M Buy
62,740
+33,297
+113% +$2.03M ﹤0.01% 1969
2021
Q3 		$1.92M Buy
29,443
+20,127
+216% +$1.37M ﹤0.01% 2391
2021
Q2 		$591K Sell
9,316
-16,231
-64% -$958K ﹤0.01% 2977
2021
Q1 		$1.53M Buy
25,547
+14,981
+142% +$815K ﹤0.01% 2500
2020
Q4 		$528K Sell
10,566
-3,488
-25% -$164K ﹤0.01% 3200
2020
Q3 		$718K Sell
14,054
-2,724
-16% -$114K ﹤0.01% 2957
2020
Q2 		$588K Buy
16,778
+10,609
+172% +$365K ﹤0.01% 3211
2020
Q1 		$157K Sell
6,169
-9,459
-61% -$281K ﹤0.01% 4478
2019
Q4 		$433K Buy
15,628
+8,013
+105% +$191K ﹤0.01% 4414
2019
Q3 		$205K Sell
7,615
-2,344
-24% -$81.7K ﹤0.01% 4950
2019
Q2 		$408K Sell
9,959
-10,720
-52% -$301K ﹤0.01% 4509
2019
Q1 		$495K Buy
20,679
+18,683
+936% +$339K ﹤0.01% 4133
2018
Q4 		$31K Buy
+1,996
New +$29.7K ﹤0.01% 5720

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Barclays's AXNX Position: Q4 2024 in Review

Barclays sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 96,378 shares — an estimated $6.71M sold.

Barclays first reported a position in AXNX in Q4 2018 and held it in 24 quarters. The position peaked at $7.33M in Q4 2023. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Barclays reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Barclays sold 96,378 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $6.71M.
  • Barclays first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
  • Barclays's Axonics, Inc. Common Stock position peaked at $7.33M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.